HCA HEALTHCARE INC (HCA) Stock Analyst Earnings Estimates
NYSE:HCA - New York Stock Exchange, Inc. - US40412C1018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60.233B 2.52% | 64.968B 7.86% | 70.603B 8.67% | 75.395B 6.79% | 79.283B 5.16% | 83.459B 5.27% | 90.503B 8.44% | 94.875B 4.83% | 99.307B 4.67% | 103.93B 4.66% | 108.697B 4.59% | |
| EBITDA YoY % growth | 12.022B -4.06% | 12.704B 5.67% | 13.859B 9.09% | 14.859B 7.22% | 15.598B 4.97% | 16.434B 5.36% | 17.552B 6.80% | 18.4B 4.83% | 19.26B 4.67% | 20.157B 4.66% | 21.082B 4.59% | |
| EBIT YoY % growth | 9.053B -6.46% | 9.627B 6.34% | 10.547B 9.56% | 11.298B 7.12% | 11.911B 5.43% | 12.51B 5.03% | 13.032B 4.17% | 13.662B 4.83% | 14.301B 4.68% | 14.966B 4.65% | 15.652B 4.58% | |
| Operating Margin | 15.03% | 14.82% | 14.94% | 14.99% | 15.02% | 14.99% | 14.40% | 14.40% | 14.40% | 14.40% | 14.40% | |
| EPS YoY % growth | 16.90 -3.43% | 18.66 10.41% | 22.12 18.54% | 25.14 13.64% | 28.37 12.86% | 31.66 11.59% | 35.59 12.42% | 39.21 10.16% | 42.95 9.53% | 46.90 9.22% | 50.97 8.68% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.85 -1.31% | 6.32 14.35% | 5.67 12.74% | 7.40 31.39% | 6.64 13.51% | 7.00 10.72% | 6.34 11.82% | 7.99 7.96% | 7.59 14.25% | 8.12 15.91% | 7.33 15.56% | 9.29 16.35% |
| Revenue Q2Q % growth | 18.417B 6.22% | 18.604B 6.36% | 18.616B 6.46% | 19.566B 7.01% | 19.428B 5.49% | 19.551B 5.09% | 19.571B 5.13% | 20.629B 5.43% | 20.462B 5.32% | 20.692B 5.84% | 20.714B 5.84% | 21.745B 5.41% |
| EBITDA Q2Q % growth | 3.562B 6.17% | 3.733B -14.09% | 3.486B -28.36% | 4.054B -34.17% | 3.796B 6.57% | 3.939B 5.52% | 3.694B 5.97% | 4.26B 5.08% | 4.01B 5.64% | 4.237B 7.57% | 3.959B 7.17% | 4.543B 6.64% |
| EBIT Q2Q % growth | 2.693B 5.20% | 2.845B 4.17% | 2.606B 8.13% | 3.147B 10.58% | 2.871B 6.61% | 3.009B 5.76% | 2.747B 5.41% | 3.348B 6.39% | 3.023B 5.29% | 3.241B 7.71% | 2.952B 7.46% | 3.501B 4.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 5.63 -5.06% | 6.18 | -0.55 | -8.93% |
| Q3 2024 Q2Q % growth | 5.03 28.64% | 5.04 | -0.01 | -0.18% |
| Q2 2024 Q2Q % growth | 5.53 28.90% | 4.90 | 0.63 | 12.83% |
| Q1 2024 Q2Q % growth | 5.93 30.91% | 5.04 | 0.89 | 17.74% |
| Q4 2023 Q2Q % growth | 5.93 27.80% | 5.11 | 0.82 | 15.99% |
| Q3 2023 Q2Q % growth | 3.91 -0.51% | 4.02 | -0.11 | -2.67% |
| Q2 2023 Q2Q % growth | 4.29 1.90% | 4.27 | 0.02 | 0.57% |
| Q1 2023 Q2Q % growth | 4.53 9.95% | 3.97 | 0.56 | 14.11% |
| Q4 2022 Q2Q % growth | 4.64 4.98% | 4.83 | -0.19 | -3.95% |
| Q3 2022 Q2Q % growth | 3.93 -14.00% | 3.92 | 0.01 | 0.26% |
| Q2 2022 Q2Q % growth | 4.21 -3.66% | 3.74 | 0.47 | 12.68% |
| Q1 2022 Q2Q % growth | 4.12 -0.48% | 4.29 | -0.17 | -3.99% |
| Q4 2021 Q2Q % growth | 4.42 7.02% | 4.58 | -0.16 | -3.45% |
| Q3 2021 Q2Q % growth | 4.57 138.02% | 4.13 | 0.44 | 10.66% |
| Q2 2021 Q2Q % growth | 4.37 191.33% | 3.19 | 1.18 | 36.81% |
| Q1 2021 Q2Q % growth | 4.14 77.68% | 3.36 | 0.78 | 23.30% |
| Q4 2020 Q2Q % growth | 4.13 33.66% | 3.64 | 0.49 | 13.43% |
| Q3 2020 Q2Q % growth | 1.92 -13.90% | 2.34 | -0.42 | -18.01% |
| Q2 2020 Q2Q % growth | 1.50 -32.13% | -0.39 | 1.89 | 479.94% |
| Q1 2020 Q2Q % growth | 2.33 -21.55% | 2.66 | -0.33 | -12.55% |
| Q4 2019 Q2Q % growth | 3.09 | 3.12 | -0.03 | -0.96% |
| Q3 2019 Q2Q % growth | 2.23 | 2.15 | 0.08 | 3.77% |
| Q2 2019 Q2Q % growth | 2.21 | 2.49 | -0.28 | -11.18% |
| Q1 2019 Q2Q % growth | 2.97 | 2.35 | 0.62 | 26.48% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 18.285B 5.68% | 18.413B | -128M | -0.70% |
| Q3 2024 Q2Q % growth | 17.487B 7.86% | 17.713B | -226M | -1.28% |
| Q2 2024 Q2Q % growth | 17.492B 10.28% | 17.217B | 275M | 1.60% |
| Q1 2024 Q2Q % growth | 17.339B 11.21% | 16.947B | 392M | 2.31% |
| Q4 2023 Q2Q % growth | 17.303B 11.65% | 16.682B | 621M | 3.72% |
| Q3 2023 Q2Q % growth | 16.213B 8.30% | 15.981B | 232M | 1.45% |
| Q2 2023 Q2Q % growth | 15.861B 7.02% | 15.772B | 89M | 0.56% |
| Q1 2023 Q2Q % growth | 15.591B 4.32% | 15.419B | 172M | 1.12% |
| Q4 2022 Q2Q % growth | 15.497B 2.87% | 15.767B | -270M | -1.71% |
| Q3 2022 Q2Q % growth | 14.971B -2.00% | 15.151B | -180M | -1.19% |
| Q2 2022 Q2Q % growth | 14.82B 2.67% | 14.872B | -52M | -0.35% |
| Q1 2022 Q2Q % growth | 14.945B 6.93% | 14.886B | 59M | 0.40% |
| Q4 2021 Q2Q % growth | 15.064B 5.39% | 15.526B | -462M | -2.98% |
| Q3 2021 Q2Q % growth | 15.276B 14.76% | 14.628B | 648M | 4.43% |
| Q2 2021 Q2Q % growth | 14.435B 30.42% | 13.756B | 679M | 4.94% |
| Q1 2021 Q2Q % growth | 13.977B 8.68% | 13.772B | 205M | 1.49% |
| Q4 2020 Q2Q % growth | 14.293B 5.69% | 14.131B | 162M | 1.15% |
| Q3 2020 Q2Q % growth | 13.311B 4.86% | 12.996B | 315M | 2.42% |
| Q2 2020 Q2Q % growth | 11.068B -12.17% | 10.192B | 876M | 8.59% |
| Q1 2020 Q2Q % growth | 12.861B 2.75% | 13.245B | -384M | -2.90% |
| Q4 2019 Q2Q % growth | 13.523B | 13.502B | 21M | 0.16% |
| Q3 2019 Q2Q % growth | 12.694B | 12.623B | 71M | 0.56% |
| Q2 2019 Q2Q % growth | 12.602B | 12.739B | -137M | -1.08% |
| Q1 2019 Q2Q % growth | 12.517B | 12.443B | 74M | 0.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.01% | -1.19% | 1.52% | 1.09% |
| Revenue | -0.19% | 0.12% | -0.15% | -0.38% |